Vaestra Goetalandsregionen — Sponsor Intelligence | 39 EU Trials

Filter these 39 trials by condition, phase, country and more.

Open in Search →

39 Registered trials

20 Recruiting

14 Completed trials

9 Countries active

66 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 8 Phase II: 15 Phase I/II: 1 Phase IV: 12 Phase I (Other): 2 Phase I (FiH): 1

100%

14 of 14 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Acute myocardial infarction 1 Therapy cessation 1 Metastases to liver 1 Congenital myopathy 1 Uveal melanoma 1 Compulsive sexual behaviour 1 Triple negative breast cancer 1

Top IMPs

SODIUM CHLORIDE 3 NIVOLUMAB 2 2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE 1 ADENOSINE 1 AFLIBERCEPT 1 ALDESLEUKIN 1 ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, RABBIT 1 ANTITHYMOCYTE IMMUNOGLOBULIN 1 ARGIPRESSIN 1 BEVACIZUMAB 1 BUSULFAN 1 CAPECITABINE 1

All trials — page 2

39 total

A phase Ib/II randomized double-blind placebo controlled trial evaluating the effect of nivolumab for patients with in-transit melanoma meta… Recruiting

2023-509265-21-00 Phase II 2 countries NIVOLUMAB
Effects of an Opioid Sparing Care Pathway for Patients undergoing Obesity Surgery Recruiting

2023-505934-86-00 Phase IV 1 country
NOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years Recruiting

2024-518254-16-00 Phase III 7 countries
SYNERGY OSA Ended

2023-510519-20-00 Phase II 2 countries SULTIAME
Phase I trial with 177Lu-DOTA-TATE and olaparib in somatostatin receptor positive tumours Ended

2024-512463-31-00 Phase I (Other) 1 country
Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736). An open label randomized phase II trial with durvalumab following Stereotacti… Ended

2024-512439-54-01 Phase II 3 countries DURVALUMAB
A Randomized Intervention, Multi-Center Study to Determine the Role of Dexamethasone eye drops against proliferative retinopathy of prematur… Ended

2023-505318-97-00 Phase III 1 country DEXAMETHASONE PHOSPHATE
Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, … Ended

2024-512844-40-00 Phase IV 2 countries PROGESTERONE
The Sahlgrenska Anti-VEGF (SAHLVE) Study - a Prospective Randomized Double-blind Comparison of Bevacizumab and Aflibercept in Patients With … Ended

2023-506317-22-00 Phase II 1 country AFLIBERCEPT; BEVACIZUMAB
Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in pati… Ended

2023-508551-40-00 Phase IV 5 countries
A Phase I Study Using Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients with Melanoma and Liver Metastases Ended

2024-512877-28-00 Phase I (Other) 1 country
Influence of Argipressin on blood loss during liver resection; a double-blinded, randomized, placebo-controlled trial (ARG-01) Ended

2024-514332-25-00 Phase II 1 country ARGIPRESSIN; SODIUM CHLORIDE
Ticagrelor monotherapy after coronary stenting in patients with acute myocardial infarction - A prospective single-centre, single-arm phase … Ended

2024-514224-17-00 Phase II 1 country TICAGRELOR
Congenital myopathy intervention study Ended

2024-512027-36-00 Phase IV 1 country SALBUTAMOL
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure (OPRA-HF) Ended

2024-511502-24-02 Phase II 1 country

Showing 25–39 of 39 trials

← All sponsors A–Z